Why this $300 million biotech IPO could be huge — or another flop in Alzheimer’s and ALS

Denali upsized the number of shares available in its IPO by more than 6 million, translating into a potential $303 million offering before the shares hit the market Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.